Virus News and Research

Latest Virus News and Research

Researchers review materials used to design biosensors for SARS-CoV-2 detection

The SARS-CoV-2 virus is still causing a dramatic loss of human lives worldwide, constituting an unprecedented challenge for society, public health, and economy, to overcome. Currently, SARS-CoV-2 can be diagnosed in two different ways: i) antigen tests (point-of-care, POC) and ii) molecular tests (nucleic acid, RNA, or PCR-polymerase chain reaction).

30 Apr 2021

People living with a child attending in-person schooling have high risk of COVID-19

People living with a child who attends school in-person have an increased risk of reporting evidence of COVID-19, but teacher masking, symptom screening, and other mitigation measures in schools may be able to minimize that excess risk, suggests a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

30 Apr 2021

Study: Republicans became increasingly vaccine hesitant over the course of the pandemic

Individuals who self-identify as Republicans became more skeptical of a potential COVID-19 vaccine and other inoculations, such as the flu shot, over the course of the pandemic, reveals a new study by the University of California San Diego's Rady School of Management.

30 Apr 2021

Study: LFDs are inaccurate at diagnosing SARS-CoV-2 infections in individuals with lower viral loads

The United Kingdom government plans to implement mass scale population testing for SARS-CoV-2 infection using Lateral Flow Devices (LFDs), yet the devices' sensitivity is unknown

30 Apr 2021

Human to animal transmission of SARS-CoV-2 in households is common

Coronaviruses are seen in multiple mammalian species. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic, is said to have passed to humans from a mammalian source and to have originated from an animal reservoir as a zoonotic pathogen.

29 Apr 2021

Monoclonal antibody CT-P59 shows preclinical efficacy against South African SARS-CoV-2 variant

Researchers in the Republic of Korea (South Korea), The Netherlands, and South Africa have demonstrated the potential of the monoclonal antibody CT-P59 as an effective therapeutic for coronavirus disease 2019 (COVID-19) caused by the South African B.1.351 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

29 Apr 2021

"COVID-19 diarrhea" depends on inflammatory response that is part of the disease

Researchers in the United States have provided important insights into the pathophysiology of diarrhea that occurs in some cases of coronavirus disease 2019 (COVID-19).

29 Apr 2021

Workplace exposure to the virus can be the cause of excess COVID-19 mortality among Hispanics

Hispanic Americans have died of COVID-19 at a disproportionately high rate compared to whites because of workplace exposure to the virus, a new study suggests.

29 Apr 2021

Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine

Last Friday, the Centers for Disease Control and Prevention and the U.S. Food & Drug Administration lifted the pause in administration of the Johnson & Johnson (Janssen) COVID-19 vaccine in the U.S.

29 Apr 2021

Study finds low risk of infection in babies born to mothers tested positive for SARS-CoV-2

Researchers at Karolinska Institutet and the Public Health Agency of Sweden have studied newborn babies whose mothers tested positive for SARS-CoV-2 during pregnancy or childbirth.

29 Apr 2021

Touching contaminated surfaces can transfer SARS-CoV-2 to skin, finds study

Using artificial skin, researchers found that touching surfaces contaminated with SARS-CoV-2 can lead to transfer of virus to the skin.

29 Apr 2021

A ‘dose of hope’? Fact-checking President Joe Biden’s first speech to Congress

In his first speech before Congress, President Joe Biden argued it was time to turn the coronavirus pandemic into a historic opportunity to expand government for the benefit of a wider range of Americans, urging investments in jobs, climate change, child care, infrastructure and more.

29 Apr 2021

Is Hong Kong’s fourth wave of COVID-19 due to the Q57H SARS-CoV-2 variant?

A recent article in the Centers for Disease Control and Prevention (CDC)’s Emerging Infectious Diseases reveals that the last of these was probably due to the introduction of a new variant from Nepal. This novel variant had been circulating in the community for about a month before the last outbreak was reported.

29 Apr 2021

COVID-19 vaccination willingness in Australia hinges on public perception of health threat

A new study reports the results of a survey in Australia on vaccine willingness at two points: the first wave in April 2020, and during November of the same year, when cases had dropped significantly.

29 Apr 2021

Researchers discover how SARS-CoV-2 hijacks human cell machinery to blunt immune response

Researchers at University of California San Diego School of Medicine have discovered one way in which SARS-CoV-2, the coronavirus that causes COVID-19, hijacks human cell machinery to blunt the immune response, allowing it to establish infection, replicate and cause disease.

29 Apr 2021

Texas A&M AgriLife receives grant to support research on bacteriophage therapy

The National Institute of Allergy and Infectious Diseases, NIAID, part of the National Institutes of Health, NIH, has awarded $2.5 million in grants to support research on bacteriophage therapy, and Texas A&M AgriLife Research is among the grant recipients.

29 Apr 2021

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration of infection may increase the incidence of mutations.

29 Apr 2021

Study: Failure to combat second-dose vaccine attrition could prolong the pandemic

Though more than 131 million Americans have received at least one dose of COVID-19 vaccine to date, public confusion and uncertainty about the importance of second doses and continued public health precautions threaten to delay a U.S. return to normalcy, according to Cornell-led research published April 28 in the New England Journal of Medicine.

29 Apr 2021

New insights into how South African SARS-CoV-2 variant sacrifices tight binding for antibody evasion

The highly infectious SARS-CoV-2 variant that recently emerged in South Africa, known as B.1.351, has scientists wondering how existing COVID-19 vaccines and therapies can be improved to ensure strong protection.

29 Apr 2021

Long COVID also affects children, study finds

Older children and children with allergies or asthma were found to have greater odds of having persistent symptoms even months after recovery.

28 Apr 2021

Virus News and Research

Latest Virus News and Research

Researchers review materials used to design biosensors for SARS-CoV-2 detection

People living with a child attending in-person schooling have high risk of COVID-19

Study: Republicans became increasingly vaccine hesitant over the course of the pandemic

Study: LFDs are inaccurate at diagnosing SARS-CoV-2 infections in individuals with lower viral loads

Human to animal transmission of SARS-CoV-2 in households is common

Monoclonal antibody CT-P59 shows preclinical efficacy against South African SARS-CoV-2 variant

"COVID-19 diarrhea" depends on inflammatory response that is part of the disease

Workplace exposure to the virus can be the cause of excess COVID-19 mortality among Hispanics

Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine

Study finds low risk of infection in babies born to mothers tested positive for SARS-CoV-2

Touching contaminated surfaces can transfer SARS-CoV-2 to skin, finds study

A ‘dose of hope’? Fact-checking President Joe Biden’s first speech to Congress

Is Hong Kong’s fourth wave of COVID-19 due to the Q57H SARS-CoV-2 variant?

COVID-19 vaccination willingness in Australia hinges on public perception of health threat

Researchers discover how SARS-CoV-2 hijacks human cell machinery to blunt immune response

Texas A&M AgriLife receives grant to support research on bacteriophage therapy

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

Study: Failure to combat second-dose vaccine attrition could prolong the pandemic

New insights into how South African SARS-CoV-2 variant sacrifices tight binding for antibody evasion

Long COVID also affects children, study finds

A new way of characterising biomolecules eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in